{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T04:09:42Z","timestamp":1775534982032,"version":"3.50.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2016,4,6]],"date-time":"2016-04-06T00:00:00Z","timestamp":1459900800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1007\/s00109-016-1415-2","type":"journal-article","created":{"date-parts":[[2016,4,6]],"date-time":"2016-04-06T00:44:29Z","timestamp":1459903469000},"page":"899-910","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Primary melanoma tumor inhibits metastasis through alterations in systemic hemostasis"],"prefix":"10.1007","volume":"94","author":[{"given":"Jennifer M.","family":"Kirstein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Nicole","family":"Hague","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia M.","family":"McGowan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan B.","family":"Tuck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann F.","family":"Chambers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,4,6]]},"reference":[{"issue":"8","key":"1415_CR1","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nrc865","volume":"2","author":"AF Chambers","year":"2002","unstructured":"Chambers AF, Groom AC, MacDonald IC (2002) Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2(8):563\u2013572","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"1415_CR2","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1158\/2159-8290.CD-12-0329","volume":"2","author":"M Labelle","year":"2012","unstructured":"Labelle M, Hynes RO (2012) The initial hours of metastasis: the importance of cooperative host-tumor cell interactions during hematogenous dissemination. Cancer Discov 2(12):1091\u20131099","journal-title":"Cancer Discov"},{"issue":"6","key":"1415_CR3","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1007\/s00418-008-0530-8","volume":"130","author":"G Lorusso","year":"2008","unstructured":"Lorusso G, Ruegg C (2008) The tumor microenvironment and its contribution to tumor evolution toward metastasis. Histochem Cell Biol 130(6):1091\u20131103","journal-title":"Histochem Cell Biol"},{"issue":"24","key":"1415_CR4","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1093\/jnci\/81.24.1893","volume":"81","author":"WH Clark Jr","year":"1989","unstructured":"Clark WH Jr, Elder DE, Guerry D, Braitman LE, Trock BJ, Schultz D, Synnestvedt M, Halpern AC (1989) Model predicting survival in stage I melanoma based on tumor progression. J Natl Cancer Inst 81(24):1893\u20131904","journal-title":"J Natl Cancer Inst"},{"issue":"11","key":"1415_CR5","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1093\/annonc\/mdn386","volume":"19","author":"R Demicheli","year":"2008","unstructured":"Demicheli R, Retsky MW, Hrushesky WJ, Baum M, Gukas ID (2008) The effects of surgery on tumor growth: a century of investigations. Ann Oncol 19(11):1821\u20131828","journal-title":"Ann Oncol"},{"issue":"1","key":"1415_CR6","first-page":"2","volume":"51","author":"RT Prehn","year":"1991","unstructured":"Prehn RT (1991) The inhibition of tumor growth by tumor mass. Cancer Res 51(1):2\u20134","journal-title":"Cancer Res"},{"key":"1415_CR7","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0065-230X(08)61033-7","volume":"39","author":"E Gorelik","year":"1983","unstructured":"Gorelik E (1983) Concomitant tumor immunity and the resistance to a second tumor challenge. Adv Cancer Res 39:71\u2013120","journal-title":"Adv Cancer Res"},{"issue":"2","key":"1415_CR8","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.canlet.2012.05.021","volume":"324","author":"P Chiarella","year":"2012","unstructured":"Chiarella P, Bruzzo J, Meiss RP, Ruggiero RA (2012) Concomitant tumor resistance. Cancer Lett 324(2):133\u2013141","journal-title":"Cancer Lett"},{"issue":"1","key":"1415_CR9","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s10555-013-9449-1","volume":"33","author":"CM Galmarini","year":"2014","unstructured":"Galmarini CM, Tredan O, Galmarini FC (2014) Concomitant resistance and early-breast cancer: should we change treatment strategies? Cancer Metastasis Rev 33(1):271\u2013283","journal-title":"Cancer Metastasis Rev"},{"issue":"2","key":"1415_CR10","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0092-8674(94)90200-3","volume":"79","author":"MS O\u2019Reilly","year":"1994","unstructured":"O\u2019Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, Lane WS, Cao Y, Sage EH, Folkman J (1994) Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79(2):315\u2013328","journal-title":"Cell"},{"issue":"2","key":"1415_CR11","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/nm0295-149","volume":"1","author":"L Holmgren","year":"1995","unstructured":"Holmgren L, O\u2019Reilly MS, Folkman J (1995) Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med 1(2):149\u2013153","journal-title":"Nat Med"},{"issue":"2","key":"1415_CR12","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/BF03401559","volume":"1","author":"J Folkman","year":"1995","unstructured":"Folkman J (1995) Angiogenesis inhibitors generated by tumors. Mol Med 1(2):120\u2013122","journal-title":"Mol Med"},{"issue":"6","key":"1415_CR13","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/nm0696-689","volume":"2","author":"MS O\u2019Reilly","year":"1996","unstructured":"O\u2019Reilly MS, Holmgren L, Chen C, Folkman J (1996) Angiostatin induces and sustains dormancy of human primary tumors in mice. Nat Med 2(6):689\u2013692","journal-title":"Nat Med"},{"issue":"5","key":"1415_CR14","first-page":"1053","volume":"7","author":"M Franco","year":"2000","unstructured":"Franco M, Bustuoabad OD, Di Gianni PD, Meiss RP, Vanzulli S, Buggiano V, Pasqualini CD, Ruggiero RA (2000) Two different types of concomitant resistance induced by murine tumors: morphological aspects and intrinsic mechanisms. Oncol Rep 7(5):1053\u20131063","journal-title":"Oncol Rep"},{"issue":"6","key":"1415_CR15","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1084\/jem.20041130","volume":"200","author":"MJ Turk","year":"2004","unstructured":"Turk MJ, Guevara-Patino JA, Rizzuto GA, Engelhorn ME, Sakaguchi S, Houghton AN (2004) Concomitant tumor immunity to a poorly immunogenic melanoma is prevented by regulatory T cells. J Exp Med 200(6):771\u2013782","journal-title":"J Exp Med"},{"issue":"1","key":"1415_CR16","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.beha.2008.12.009","volume":"22","author":"A Falanga","year":"2009","unstructured":"Falanga A, Panova-Noeva M, Russo L (2009) Procoagulant mechanisms in tumour cells. Best Pract Res Clin Haematol 22(1):49\u201360","journal-title":"Best Pract Res Clin Haematol"},{"issue":"2","key":"1415_CR17","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s10585-008-9221-z","volume":"26","author":"JM Kirstein","year":"2009","unstructured":"Kirstein JM, Graham KC, Mackenzie LT, Johnston DE, Martin LJ, Tuck AB, MacDonald IC, Chambers AF (2009) Effect of anti-fibrinolytic therapy on experimental melanoma metastasis. Clin Exp Metastasis 26(2):121\u2013131","journal-title":"Clin Exp Metastasis"},{"issue":"23","key":"1415_CR18","doi-asserted-by":"crossref","first-page":"8613","DOI":"10.1158\/0008-5472.CAN-04-2078","volume":"64","author":"JH Im","year":"2004","unstructured":"Im JH, Fu W, Wang H, Bhatia SK, Hammer DA, Kowalska MA, Muschel RJ (2004) Coagulation facilitates tumor cell spreading in the pulmonary vasculature during early metastatic colony formation. Cancer Res 64(23):8613\u20138619","journal-title":"Cancer Res"},{"issue":"1","key":"1415_CR19","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1182\/blood-2004-06-2272","volume":"105","author":"JS Palumbo","year":"2005","unstructured":"Palumbo JS, Talmage KE, Massari JV, La Jeunesse CM, Flick MJ, Kombrinck KW, Jirouskova M, Degen JL (2005) Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells. Blood 105(1):178\u2013185","journal-title":"Blood"},{"issue":"17","key":"1415_CR20","first-page":"4549","volume":"51","author":"N Esumi","year":"1991","unstructured":"Esumi N, Fan D, Fidler IJ (1991) Inhibition of murine melanoma experimental metastasis by recombinant desulfatohirudin, a highly specific thrombin inhibitor. Cancer Res 51(17):4549\u20134556","journal-title":"Cancer Res"},{"issue":"10","key":"1415_CR21","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.1182\/blood.V96.10.3302","volume":"96","author":"JS Palumbo","year":"2000","unstructured":"Palumbo JS, Kombrinck KW, Drew AF, Grimes TS, Kiser JH, Degen JL, Bugge TH (2000) Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells. Blood 96(10):3302\u20133309","journal-title":"Blood"},{"issue":"23","key":"1415_CR22","first-page":"6966","volume":"62","author":"JS Palumbo","year":"2002","unstructured":"Palumbo JS, Potter JM, Kaplan LS, Talmage K, Jackson DG, Degen JL (2002) Spontaneous hematogenous and lymphatic metastasis, but not primary tumor growth or angiogenesis, is diminished in fibrinogen-deficient mice. Cancer Res 62(23):6966\u20136972","journal-title":"Cancer Res"},{"issue":"8","key":"1415_CR23","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1182\/blood-2003-03-0881","volume":"102","author":"JS Palumbo","year":"2003","unstructured":"Palumbo JS, Talmage KE, Liu H, La Jeunesse CM, Witte DP, Degen JL (2003) Plasminogen supports tumor growth through a fibrinogen-dependent mechanism linked to vascular patency. Blood 102(8):2819\u20132827","journal-title":"Blood"},{"issue":"1","key":"1415_CR24","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1182\/blood-2007-01-065995","volume":"110","author":"JS Palumbo","year":"2007","unstructured":"Palumbo JS, Talmage KE, Massari JV, La Jeunesse CM, Flick MJ, Kombrinck KW, Hu Z, Barney KA, Degen JL (2007) Tumor cell-associated tissue factor and circulating hemostatic factors cooperate to increase metastatic potential through natural killer cell-dependent and-independent mechanisms. Blood 110(1):133\u2013141","journal-title":"Blood"},{"issue":"5","key":"1415_CR25","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/j.1538-7836.2008.02938.x","volume":"6","author":"JS Palumbo","year":"2008","unstructured":"Palumbo JS, Barney KA, Blevins EA, Shaw MA, Mishra A, Flick MJ, Kombrinck KW, Talmage KE, Souri M, Ichinose A et al (2008) Factor XIII transglutaminase supports hematogenous tumor cell metastasis through a mechanism dependent on natural killer cell function. J Thromb Haemost 6(5):812\u2013819","journal-title":"J Thromb Haemost"},{"issue":"5","key":"1415_CR26","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/CMR.0b013e32832e40fe","volume":"19","author":"C Kirszberg","year":"2009","unstructured":"Kirszberg C, Lima LG, Da Silva de Oliveira A, Pickering W, Gray E, Barrowcliffe TW, Rumjanek VM, Monteiro RQ (2009) Simultaneous tissue factor expression and phosphatidylserine exposure account for the highly procoagulant pattern of melanoma cell lines. Melanoma Res 19(5):301\u2013308","journal-title":"Melanoma Res"},{"issue":"2","key":"1415_CR27","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nrc3004","volume":"11","author":"LJ Gay","year":"2011","unstructured":"Gay LJ, Felding-Habermann B (2011) Contribution of platelets to tumour metastasis. Nat Rev Cancer 11(2):123\u2013134","journal-title":"Nat Rev Cancer"},{"issue":"7","key":"1415_CR28","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s10585-009-9264-9","volume":"26","author":"CE Holmes","year":"2009","unstructured":"Holmes CE, Levis JE, Ornstein DL (2009) Activated platelets enhance ovarian cancer cell invasion in a cellular model of metastasis. Clin Exp Metastasis 26(7):653\u2013661","journal-title":"Clin Exp Metastasis"},{"key":"1415_CR29","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1186\/s12885-015-1304-z","volume":"15","author":"R Orellana","year":"2015","unstructured":"Orellana R, Kato S, Erices R, Bravo ML, Gonzalez P, Oliva B, Cubillos S, Valdivia A, Ibanez C, Branes J et al (2015) Platelets enhance tissue factor protein and metastasis initiating cell markers, and act as chemoattractants increasing the migration of ovarian cancer cells. BMC Cancer 15:290","journal-title":"BMC Cancer"},{"issue":"11","key":"1415_CR30","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S0301-472X(01)00733-0","volume":"29","author":"A Schmitt","year":"2001","unstructured":"Schmitt A, Guichard J, Masse JM, Debili N, Cramer EM (2001) Of mice and men: comparison of the ultrastructure of megakaryocytes and platelets. Exp Hematol 29(11):1295\u20131302","journal-title":"Exp Hematol"},{"issue":"1","key":"1415_CR31","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.exphem.2003.09.024","volume":"32","author":"A Musaji","year":"2004","unstructured":"Musaji A, Vanhoorelbeke K, Deckmyn H, Coutelier JP (2004) New model of transient strain-dependent autoimmune thrombocytopenia in mice immunized with rat platelets. Exp Hematol 32(1):87\u201394","journal-title":"Exp Hematol"},{"issue":"7","key":"1415_CR32","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider CA, Rasband WS, Eliceiri KW (2012) NIH Image to ImageJ: 25 years of image analysis. Nat Methods 9(7):671\u2013675","journal-title":"Nat Methods"},{"key":"1415_CR33","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/B978-012369454-6\/50059-5","volume-title":"The mouse in biomedical research","author":"NE Everds","year":"2007","unstructured":"Everds NE (2007) Hematology of the laboratory mouse. In: Fox JG, Davisson MT, Quimby FW, Barthold SW, Newcomer CE, Smith AL (eds) The mouse in biomedical research, vol 3, 2nd edn. Elsevier, Inc., Burlington, pp 133\u2013170","edition":"2"},{"issue":"7069","key":"1415_CR34","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/nature04186","volume":"438","author":"RN Kaplan","year":"2005","unstructured":"Kaplan RN, Riba RD, Zacharoulis S, Bramley AH, Vincent L, Costa C, MacDonald DD, Jin DK, Shido K, Kerns SA et al (2005) VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438(7069):820\u2013827","journal-title":"Nature"},{"issue":"2","key":"1415_CR35","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/bjc.1996.335","volume":"74","author":"M Franco","year":"1996","unstructured":"Franco M, Bustuoabad OD, di Gianni PD, Goldman A, Pasqualini CD, Ruggiero RA (1996) A serum-mediated mechanism for concomitant resistance shared by immunogenic and non-immunogenic murine tumours. Br J Cancer 74(2):178\u2013186","journal-title":"Br J Cancer"},{"issue":"1","key":"1415_CR36","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/bjc.1985.6","volume":"51","author":"RA Ruggiero","year":"1985","unstructured":"Ruggiero RA, Bustuoabad OD, Bonfil RD, Meiss RP, Pasqualini CD (1985) \u201cConcomitant immunity\u201d in murine tumours of non-detectable immunogenicity. Br J Cancer 51(1):37\u201348","journal-title":"Br J Cancer"},{"issue":"8","key":"1415_CR37","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1586\/14737140.8.8.1247","volume":"8","author":"L Borsig","year":"2008","unstructured":"Borsig L (2008) The role of platelet activation in tumor metastasis. Expert Rev Anticancer Ther 8(8):1247\u20131255","journal-title":"Expert Rev Anticancer Ther"},{"key":"1415_CR38","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/978-0-387-79962-9_2","volume":"148","author":"DL Green","year":"2009","unstructured":"Green DL, Karpatkin S (2009) Effect of cancer on platelets. Cancer Treat Res 148:17\u201330","journal-title":"Cancer Treat Res"},{"issue":"7","key":"1415_CR39","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1470-2045(02)00789-1","volume":"3","author":"GF Nash","year":"2002","unstructured":"Nash GF, Turner LF, Scully MF, Kakkar AK (2002) Platelets and cancer. Lancet Oncol 3(7):425\u2013430","journal-title":"Lancet Oncol"},{"issue":"5","key":"1415_CR40","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1182\/blood.V96.5.1789","volume":"96","author":"OJ McCarty","year":"2000","unstructured":"McCarty OJ, Mousa SA, Bray PF, Konstantopoulos K (2000) Immobilized platelets support human colon carcinoma cell tethering, rolling, and firm adhesion under dynamic flow conditions. Blood 96(5):1789\u20131797","journal-title":"Blood"},{"issue":"3","key":"1415_CR41","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s10585-008-9227-6","volume":"26","author":"TM Niers","year":"2009","unstructured":"Niers TM, Bruggemann LW, Klerk CP, Muller FJ, Buckle T, Reitsma PH, Richel DJ, Spek CA, Van Tellingen O, Van Noorden CJ (2009) Differential effects of anticoagulants on tumor development of mouse cancer cell lines B16, K1735 and CT26 in lung. Clin Exp Metastasis 26(3):171\u2013178","journal-title":"Clin Exp Metastasis"},{"issue":"10","key":"1415_CR42","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1182\/blood-2011-03-341222","volume":"118","author":"NA Horowitz","year":"2011","unstructured":"Horowitz NA, Blevins EA, Miller WM, Perry AR, Talmage KE, Mullins ES, Flick MJ, Queiroz KC, Shi K, Spek CA et al (2011) Thrombomodulin is a determinant of metastasis through a mechanism linked to the thrombin binding domain but not the lectin-like domain. Blood 118(10):2889\u20132895","journal-title":"Blood"},{"issue":"3","key":"1415_CR43","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF00121171","volume":"11","author":"M Kimoto","year":"1993","unstructured":"Kimoto M, Ando K, Koike S, Matsumoto T, Jibu T, Moriya H, Kanegasaki S (1993) Significance of platelets in an antimetastatic activity of bacterial lipopolysaccharide. Clin Exp Metastasis 11(3):285\u2013292","journal-title":"Clin Exp Metastasis"},{"issue":"2","key":"1415_CR44","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/BF00058058","volume":"5","author":"AK Kimura","year":"1987","unstructured":"Kimura AK, Mehta P, Xiang JH, Lawson D, Dugger D, Kao KJ, Lee-Ambrose L (1987) The lack of correlation between experimental metastatic potential and platelet aggregating activity of B16 melanoma clones viewed in relation to tumor cell heterogeneity. Clin Exp Metastasis 5(2):125\u2013133","journal-title":"Clin Exp Metastasis"},{"issue":"6","key":"1415_CR45","first-page":"1460","volume":"48","author":"M Mahalingam","year":"1988","unstructured":"Mahalingam M, Ugen KE, Kao KJ, Klein PA (1988) Functional role of platelets in experimental metastasis studied with cloned murine fibrosarcoma cell variants. Cancer Res 48(6):1460\u20131464","journal-title":"Cancer Res"},{"issue":"1\u20132","key":"1415_CR46","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.thromres.2004.08.001","volume":"115","author":"C Kirszberg","year":"2005","unstructured":"Kirszberg C, Rumjanek VM, Monteiro RQ (2005) Assembly and regulation of prothrombinase complex on B16F10 melanoma cells. Thromb Res 115(1\u20132):123\u2013129","journal-title":"Thromb Res"},{"issue":"1","key":"1415_CR47","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1016\/j.suronc.2009.03.008","volume":"19","author":"S Kvolik","year":"2010","unstructured":"Kvolik S, Jukic M, Matijevic M, Marjanovic K, Glavas-Obrovac L (2010) An overview of coagulation disorders in cancer patients. Surg Oncol 19(1):e33\u2013e46","journal-title":"Surg Oncol"},{"issue":"2","key":"1415_CR48","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.canlet.2009.03.041","volume":"283","author":"LG Lima","year":"2009","unstructured":"Lima LG, Chammas R, Monteiro RQ, Moreira ME, Barcinski MA (2009) Tumor-derived microvesicles modulate the establishment of metastatic melanoma in a phosphatidylserine-dependent manner. Cancer Lett 283(2):168\u2013175","journal-title":"Cancer Lett"},{"issue":"1","key":"1415_CR49","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.beha.2009.01.004","volume":"22","author":"AK Kakkar","year":"2009","unstructured":"Kakkar AK (2009) Antithrombotic therapy and survival in cancer patients. Best Pract Res Clin Haematol 22(1):147\u2013151","journal-title":"Best Pract Res Clin Haematol"},{"issue":"Suppl 1","key":"1415_CR50","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1038\/sj.bjc.6605602","volume":"102","author":"AK Kakkar","year":"2010","unstructured":"Kakkar AK, Macbeth F (2010) Antithrombotic therapy and survival in patients with malignant disease. Br J Cancer 102(Suppl 1):S24\u2013S29","journal-title":"Br J Cancer"},{"issue":"2","key":"1415_CR51","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3109\/07853890.2015.1004361","volume":"47","author":"M Franchini","year":"2015","unstructured":"Franchini M, Mannucci PM (2015) Low-molecular-weight heparins and cancer: focus on antitumoral effect. Ann Med 47(2):116\u2013121","journal-title":"Ann Med"},{"issue":"5","key":"1415_CR52","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1200\/JCO.2015.64.0268","volume":"34","author":"F Macbeth","year":"2016","unstructured":"Macbeth F, Noble S, Evans J, Ahmed S, Cohen D, Hood K, Knoyle D, Linnane S, Longo M, Moore B et al (2016) Randomized phase III trial of standard therapy plus low molecular weight heparin in patients with lung cancer: FRAGMATIC trial. J Clin Oncol 34(5):488\u2013494","journal-title":"J Clin Oncol"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-016-1415-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00109-016-1415-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-016-1415-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T06:21:20Z","timestamp":1600410080000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00109-016-1415-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,6]]},"references-count":52,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["1415"],"URL":"https:\/\/doi.org\/10.1007\/s00109-016-1415-2","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,6]]}}}